Utama › Penyakit Hati Steatotik › Washington
Kajian klinikal Penyakit Hati Steatotik di Washington
7 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi di Washington.
Bandar di Washington
Teks kajian rasmi (Bahasa Inggeris)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Washington Gastroenterology - Bellevue, Bellevue
- UW Medicine Diabetes Institute, Seattle
- Washington Gastroenterology - Tacoma, Tacoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Seattle
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Seattle
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221188A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Seattle
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07221227Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
- University of Washington, Seattle
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Dis 2025 · NCT07270601Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.